Nuveen Asset Management, LLC Avalo Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $345 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.0 - $10.45 $1.22 Million - $4.23 Million
-405,047 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$7.57 - $21.72 $1.44 Million - $4.12 Million
-189,584 Reduced 31.88%
405,047 $294,000
Q4 2021

Feb 14, 2022
SELL
$19.68 - $28.68 $310,196 - $452,054
-15,762 Reduced 2.58%
594,631 $1.01 Million
Q3 2021

Nov 12, 2021
BUY
$26.16 - $40.68 $16 Million - $24.8 Million
610,393 New
610,393 $1.37 Million

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $84.9M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email